TY - JOUR
T1 - Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility
AU - Couturier, Nicolas
AU - Bucciarelli, Florence
AU - Nurtdinov, Ramil N.
AU - Debouverie, Marc
AU - Lebrun-Frenay, Christine
AU - Defer, Gilles
AU - Moreau, Thibault
AU - Confavreux, Christian
AU - Vukusic, Sandra
AU - Cournu-Rebeix, Isabelle
AU - Goertsches, Robert H.
AU - Zettl, Uwe K.
AU - Comabella, Manuel
AU - Montalban, Xavier
AU - Rieckmann, Peter
AU - Weber, Frank
AU - Müller-Myhsok, Bertram
AU - Edan, Gilles
AU - Fontaine, Bertrand
AU - Mars, Lennart T.
AU - Saoudi, Abdelhadi
AU - Oksenberg, Jorge R.
AU - Clanet, Michel
AU - Liblau, Roland S.
AU - Brassat, David
N1 - Funding Information:
The CRB-REFGENSEP ‘Génétique de la Sclérose en Plaques’ was supported by AFM, INSERM, and ARSEP. Financial support for this study came from ARSEP (French Multiple Sclerosis Society). N.C. is a fellow of the Association pour la Recherche sur la Sclérose en Plaques (ARSEP) and Association Développement Recherche Enseignement en Neurologie (ADREN).
PY - 2011/3
Y1 - 2011/3
N2 - The tyrosine kinase 2 variant rs34536443 has been established as a genetic risk factor for multiple sclerosis in a variety of populations. However, the functional effect of this variant on disease pathogenesis remains unclear. This study replicated the genetic association of tyrosine kinase 2 with multiple sclerosis in a cohort of 1366 French patients and 1802 controls. Furthermore, we assessed the functional consequences of this polymorphism on human T lymphocytes by comparing the reactivity and cytokine profile of T lymphocytes isolated from individuals expressing the protective TYK2GC genotype with the disease-associated TYK2GG genotype. Our results demonstrate that the protective C allele infers decreased tyrosine kinase 2 activity, and this reduction of activity is associated with a shift in the cytokine profile favouring the secretion of Th2 cytokines. These findings suggest that the rs34536443 variant effect on multiple sclerosis susceptibility might be mediated by deviating T lymphocyte differentiation toward a Th2 phenotype. This impact of tyrosine kinase 2 on effector differentiation is likely to be of wider importance because other autoimmune diseases also have been associated with polymorphisms within tyrosine kinase 2. The modulation of tyrosine kinase 2 activity might therefore represent a new therapeutic approach for the treatment of autoimmune diseases.
AB - The tyrosine kinase 2 variant rs34536443 has been established as a genetic risk factor for multiple sclerosis in a variety of populations. However, the functional effect of this variant on disease pathogenesis remains unclear. This study replicated the genetic association of tyrosine kinase 2 with multiple sclerosis in a cohort of 1366 French patients and 1802 controls. Furthermore, we assessed the functional consequences of this polymorphism on human T lymphocytes by comparing the reactivity and cytokine profile of T lymphocytes isolated from individuals expressing the protective TYK2GC genotype with the disease-associated TYK2GG genotype. Our results demonstrate that the protective C allele infers decreased tyrosine kinase 2 activity, and this reduction of activity is associated with a shift in the cytokine profile favouring the secretion of Th2 cytokines. These findings suggest that the rs34536443 variant effect on multiple sclerosis susceptibility might be mediated by deviating T lymphocyte differentiation toward a Th2 phenotype. This impact of tyrosine kinase 2 on effector differentiation is likely to be of wider importance because other autoimmune diseases also have been associated with polymorphisms within tyrosine kinase 2. The modulation of tyrosine kinase 2 activity might therefore represent a new therapeutic approach for the treatment of autoimmune diseases.
KW - autoimmunity
KW - multiple sclerosis
KW - susceptibility T lymphocyte polarization
KW - TYK2
UR - http://www.scopus.com/inward/record.url?scp=79952158486&partnerID=8YFLogxK
U2 - 10.1093/brain/awr010
DO - 10.1093/brain/awr010
M3 - Article
C2 - 21354972
AN - SCOPUS:79952158486
SN - 0006-8950
VL - 134
SP - 693
EP - 703
JO - Brain
JF - Brain
IS - 3
ER -